EarlyBirds Can Help with the Adoption of Healthcare Early Detection Technologies – Yahoo Finance
Forde, Dec. 05, 2022 (GLOBE NEWSWIRE) — EarlyBirds, an open innovation ecosystem platform with services innovators, early adopters, and subject matter experts (SMEs) to work with each other in finding ways to speed up technology advancement and adoption in an organisation, wants healthcare organisations to know that they can help with the adoption of new technologies such as those for early detection of disease. Early detection, such as in certain kinds of cancer like colon cancer and ovarian cancer, increases the chances of survival significantly. This is why scientists and doctors have been increasing their efforts for the development of cutting-edge technologies for detecting cancer cells early in their life.
While the early detection of diseases is an exciting development for medicine, medical ethicists are concerned that technological developments could result in computers taking too large a role in medical decision making without the evidence to support them. Thus, while algorithms can be helpful in detecting diseases as early as possible, more testing is required to ensure that there would be no false-positive diagnoses. This has to be taken into account in the development of new technologies and their adoption in the healthcare industry.
Meanwhile, several large research projects are underway for the development of new technologies where AI and Deep Learning play an important role in fighting cancer and other diseases like Alzheimer’s, arthritis, Parkinson’s, lupus, and more. Deep learning is a machine learning technology that allows computers to learn by example, which is a natural learning method used by people. AI and Machine Learning (ML) models offer various benefits for pharmaceutical companies in their development of new drugs for treating and curing various illnesses and to better monitor the severity of the disease. According to the US Government Accountability Office (GAO), researchers in the government, academic, and private sectors are working to expand the capabilities of ML-based medical diagnostic technologies. They noted three broad emerging approaches of autonomous, adaptive and consumer-oriented ML diagnostics that can be used for detecting various diseases.
Those involved in the development of new technologies are the innovator companies, which are typically start-up and scale-up companies although there are mature companies that are also involved in technological innovations. The EarlyBirds platform allows these innovators to come in contact with companies that are eager to adopt new technologies as a way to improve their products and services. In the above-mentioned cases, it is the healthcare and pharmaceutical companies that are looking for such innovations as early detection of diseases and facilitation of the development of new drugs. Innovator companies joining EarlyBirds will stand to benefit a lot, especially start-ups, because the platform allows them to be in contact with early adopters resulting into a win-win situation.
EarlyBirds can serve as the ideal partner for healthcare organisations in the development of an innovation capability map of the worldwide technology ecosystem for early detection systems. This includes the development of new drugs that will offer support for research and solution development, including clinical trials, implementation, and continuous product development. An innovation map can be specific to a project or opportunity they are focused on. The maps are dynamic, meaning they are regularly updated as new technologies emerge and current technologies evolve, offering critical information for research up to ensuring that solutions are keeping up with emerging technological innovations. The EarlyBirds open innovation ecosystem offers a way for different organisations to come together, whether they are early adopters, innovators, or SMEs. The resulting collaborations are then expected to boost speed, culture, and capacity to adopt new innovations for solving difficult challenges through their Explorer and Challenger programs.
People who would like to know more as to how the Early Birds can help with the application of advanced early detection technologies for the health care industry can check out or contact EarlyBirds at earlybirds.io.
###
For more information about EarlyBirds, contact the company here:
EarlyBirds
Mr Kris Poria and Mr Jeff Penrose
+61 401 287 060
support@earlybirds.io
‘FORDE’ SUITE 10, LEVEL 1, 26 FRANCIS FORDE BOULEVARD, FORDE, ACT 2914
Elon Musk has legions of fans who have been happy to indulge his whims, but the World’s Richest Man also has plenty of detractors. Hardly any have been as outspoken in their distrust of Musk as GLJ Research’s Gordon Johnson. The analyst has not been shy in laying out the reasons why investors should stay away from Tesla (TSLA) and now Johnson has compiled a list of “Musk promises that weren’t achieved (or, in layman terms, lies).” These range from broken Twitter pledges (not to ban anti-fascist
WASHINGTON (Reuters) -Jeff Bezos' space company Blue Origin is partnering with Boeing Co and Lockheed Martin Corp to pitch a lunar lander to NASA as the agency seeks to send humans to the moon again, the companies announced on Tuesday. The joint moon lander proposal, led by Blue Origin, marks the companies' second attempt to win a coveted moon lander contract as NASA seeks more options for getting astronauts to the lunar surface under its multibillion dollar Artemis program.
Remains of shipwrecked sailors could increase as coastal sites are exposed, say experts.
Heavy smoke billows from Russia's Kursk Airfield after drone attack, in a video sourced from telegram
The founding team spent the past several years at 10x Genomics, a pioneer in single-cell sequencing technology that could unlock new insights into using actual human antibodies as therapeutics.
TechCrunch kicked off a conversation with the large language model by asking it to explain its function and purpose. Asked about the politics of the individuals and organizations who have provided donations to fund its development, ChatGPT claimed it could not provide any info — "as my training only goes up until 2021" — and also because it said it is "not currently able to browse the internet."
The Artemis 1 mission is coming to an end, but that doesn’t mean the hard part is over. The uncrewed Orion spacecraft, currently on its way home from the Moon, must still survive a harrowing reentry through Earth’s atmosphere if it’s to perform a successful splashdown in the Pacific Ocean. NASA is hoping that a new technique, known as a skip reentry, will assist the capsule during the final leg of its long and historic journey.
Construction has begun on the world's largest radio astronomy observatory, known as the Square Kilometre Array.
A rare celestial event will occur on Dec. 7, when the moon will pass directly in front of Mars, blocking its light from view. NASA is calling it "one of those magical moments when the sky changes dramatically before your very eyes." It's called an occultation, a spooky-sounding term derived from the Latin word meaning "hidden." Occultations happen once or twice a year somewhere on the planet. But this one is exceptionally rare. "This doesn't happen very often. In fact, in 25 years of viewing, I'
The latest rocket launch schedule for Florida's Space Coast, which includes Kennedy Space Center and Cape Canaveral Space Force Station.
The company is being probed for potential violations of the Animal Welfare Act.
SpaceX's launch services have already become an invaluable resource for the U.S. government, but the company is now jumping into the deep end of the pool it had heretofore only splashed around in. Starshield, a new vertical within SpaceX, will provide "government entities" (think three-letter agencies) with secure communications and bespoke satellite designs. The new brand (possibly a subsidiary) appeared as a new top-line category on SpaceX's website, alongside Dragon, Starlink and Starship, but beyond that has not received any visible promotion or discussion in the company's media channels.
Mice lacking brain cilia were deficient in recalling information about their location and orientation in space, scientists say
Three Chinese astronauts who spent half a year aboard their country's space station have safely made it back to Earth. The astronauts – Chen Dong, Liu Yang and Cai Xuzhe – embarked on the space voyage to supervise the final construction stage of China’s Tiangong space station. All three astronauts stated they were in good condition following their arrival, as heard in audio that was aired by Chinese broadcaster CCTV.
Morgan Stanley analyst Kristine T Liwag reiterated an Overweight rating on the shares of Rocket Lab USA Inc (NASDAQ: RKLB) with a price target of $10.00. Dedicated space companies have had a tough 2022, including Rocket Lab, said the analyst. Space firms that listed in 2021 are down a median 66% YTD, compared to the S&P 500 down ~13%, as higher interest rates have effectively dimmed the outlook for over-the-horizon initiatives, the analyst added. However, the analyst sees opportunity in the mark
SpaceX is waiting a little longer for a launch from Florida’s Space Coast.
A new study finds that the Southern Hemisphere is 24% stormier than the North
Elon Musk’s Neuralink, a medical device company, is under federal investigation for potential animal-welfare violations amid internal staff complaints that its animal testing is being rushed, causing needless suffering and deaths, according to documents reviewed by Reuters and sources familiar with the investigation and company operations. Neuralink Corp is developing a brain implant it hopes will help paralyzed people walk again and cure other neurological ailments. The investigation has come at a time of growing employee dissent about Neuralink’s animal testing, including complaints that pressure from CEO Musk to accelerate development has resulted in botched experiments, according to a Reuters review of dozens of Neuralink documents and interviews with more than 20 current and former employees.
NASA's Orion spacecraft to soon return to Earth
Internal staff complaints claim Neuralink’s animal testing is being rushed, causing needless suffering and deaths